Production (Stage)
Fractyl Health, Inc.
GUTS
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -78.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -78.57% | |||
| Cost of Revenue | -- | -100.00% | |||
| Gross Profit | -- | -57.14% | |||
| SG&A Expenses | 7.95% | 2.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.80% | 5.90% | |||
| Operating Income | 1.79% | -5.95% | |||
| Income Before Tax | 4.95% | -7.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.95% | -7.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.95% | -7.75% | |||
| EBIT | 1.79% | -5.95% | |||
| EBITDA | 2.07% | -5.94% | |||
| EPS Basic | 5.76% | -6.71% | |||
| Normalized Basic EPS | 3.23% | -15.71% | |||
| EPS Diluted | 5.76% | -6.71% | |||
| Normalized Diluted EPS | 3.23% | -15.71% | |||
| Average Basic Shares Outstanding | 0.87% | 0.98% | |||
| Average Diluted Shares Outstanding | 0.87% | 0.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||